| Early‐onset colorectal cancer in young individuals G Mauri, A Sartore‐Bianchi, AG Russo, S Marsoni, A Bardelli, S Siena Molecular oncology 13 (2), 109-131, 2019 | 536 | 2019 |
| Effect of KRAS and BRAF mutations on survival of metastatic colorectal cancer after liver resection: a systematic review and meta-analysis F Tosi, E Magni, A Amatu, G Mauri, K Bencardino, M Truini, S Veronese, ... Clinical colorectal cancer 16 (3), e153-e163, 2017 | 131 | 2017 |
| Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial A Sartore-Bianchi, F Pietrantonio, S Lonardi, B Mussolin, F Rua, ... Nature Medicine 28 (8), 1612-1618, 2022 | 120 | 2022 |
| Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies G Mauri, EG Pizzutilo, A Amatu, K Bencardino, L Palmeri, EF Bonazzina, ... Cancer treatment reviews 73, 41-53, 2019 | 86 | 2019 |
| Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer F Tosi, A Sartore-Bianchi, S Lonardi, A Amatu, F Leone, S Ghezzi, ... Clinical Colorectal Cancer 19 (4), 256-262. e2, 2020 | 75 | 2020 |
| A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin S Arena, G Corti, E Durinikova, M Montone, NM Reilly, M Russo, ... Clinical Cancer Research 26 (6), 1372-1384, 2020 | 75 | 2020 |
| The Evolutionary Landscape of Treatment for BRAFV600E Mutant Metastatic Colorectal Cancer G Mauri, E Bonazzina, A Amatu, F Tosi, K Bencardino, V Gori, ... Cancers 13 (1), 137, 2021 | 68 | 2021 |
| The DNA damage response pathway as a land of therapeutic opportunities for colorectal cancer G Mauri, S Arena, S Siena, A Bardelli, A Sartore-Bianchi Annals of Oncology 31 (9), 1135-1147, 2020 | 64 | 2020 |
| Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients G Crisafulli, A Sartore-Bianchi, L Lazzari, F Pietrantonio, A Amatu, ... Cancer Discovery 12 (7), 1656-1675, 2022 | 60 | 2022 |
| Liquid biopsies to monitor and direct cancer treatment in colorectal cancer G Mauri, PP Vitiello, A Sogari, G Crisafulli, A Sartore-Bianchi, S Marsoni, ... British Journal of Cancer 127 (3), 394-407, 2022 | 55 | 2022 |
| Increased incidence of colon cancer among individuals younger than 50 years: A 17 years analysis from the cancer registry of the municipality of Milan, Italy AG Russo, A Andreano, A Sartore-Bianchi, G Mauri, A Decarli, S Siena Cancer epidemiology 60, 134-140, 2019 | 52 | 2019 |
| Strategies to tackle RAS-mutated metastatic colorectal cancer G Patelli, F Tosi, A Amatu, G Mauri, A Curaba, DA Patane, A Pani, ... ESMO open 6 (3), 100156, 2021 | 47 | 2021 |
| Parallel evaluation of circulating tumor DNA and circulating tumor cells in metastatic colorectal cancer G Germano, G Mauri, G Siravegna, C Dive, J Pierce, F Di Nicolantonio, ... Clinical colorectal cancer 17 (1), 80-83, 2018 | 46 | 2018 |
| Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi, S Siena, A Bardelli, ... Cancers 13 (11), 2638, 2021 | 43 | 2021 |
| Delphi initiative for early-onset colorectal cancer (DIRECt) international management guidelines GM Cavestro, A Mannucci, F Balaguer, H Hampel, SS Kupfer, A Repici, ... Clinical Gastroenterology and Hepatology 21 (3), 581-603. e33, 2023 | 41 | 2023 |
| Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities G Mauri, V Gori, E Bonazzina, A Amatu, F Tosi, K Bencardino, L Ruggieri, ... Cancer Treatment Reviews 91, 102112, 2020 | 38 | 2020 |
| Oxaliplatin immune-induced syndrome occurs with cumulative administration and rechallenge: single institution series and systematic review study K Bencardino, G Mauri, A Amatu, F Tosi, E Bonazzina, L Palmeri, ... Clinical colorectal cancer 15 (3), 213-221, 2016 | 37 | 2016 |
| Combined Low Densities of FoxP3+ and CD3+ Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression T Cavalleri, P Bianchi, G Basso, G Celesti, F Grizzi, P Bossi, L Greco, ... Cancer immunology research 7 (5), 751-758, 2019 | 32 | 2019 |
| Liquid biopsy for prognosis and treatment in metastatic colorectal cancer: circulating tumor cells vs circulating tumor DNA G Patelli, C Vaghi, F Tosi, G Mauri, A Amatu, D Massihnia, S Ghezzi, ... Targeted Oncology 16, 309-324, 2021 | 22 | 2021 |
| Liquid biopsy for prognosis and treatment in metastatic colorectal cancer: circulating tumor cells vs circulating tumor DNA G Patelli, C Vaghi, F Tosi, G Mauri, A Amatu, D Massihnia, S Ghezzi, ... Targeted Oncology 16, 309-324, 2021 | 22 | 2021 |
